These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products. Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182 [TBL] [Abstract][Full Text] [Related]
43. A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137. Zhang J; Li B; Qin Y; Karthik L; Zhu G; Hou C; Jiang L; Liu M; Ye X; Liu M; Hsiang T; Dai H; Zhang L; Liu X Appl Microbiol Biotechnol; 2020 Feb; 104(4):1533-1543. PubMed ID: 31894364 [TBL] [Abstract][Full Text] [Related]
44. New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade. Mi Y; Zhang J; He S; Yan X Mar Drugs; 2017 May; 15(5):. PubMed ID: 28475149 [TBL] [Abstract][Full Text] [Related]
45. Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery. Lee JY; Orlikova B; Diederich M Mar Drugs; 2015 Aug; 13(8):4967-84. PubMed ID: 26262624 [TBL] [Abstract][Full Text] [Related]
46. Cytotoxic Natural Products from Marine Sponge-Derived Microorganisms. Zhang H; Zhao Z; Wang H Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28287431 [TBL] [Abstract][Full Text] [Related]
47. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles. Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912 [TBL] [Abstract][Full Text] [Related]
48. Cryptic Metabolites from Marine-Derived Microorganisms Using OSMAC and Epigenetic Approaches. Pinedo-Rivilla C; Aleu J; Durán-Patrón R Mar Drugs; 2022 Jan; 20(2):. PubMed ID: 35200614 [TBL] [Abstract][Full Text] [Related]
49. Discovery of potent broad spectrum antivirals derived from marine actinobacteria. Raveh A; Delekta PC; Dobry CJ; Peng W; Schultz PJ; Blakely PK; Tai AW; Matainaho T; Irani DN; Sherman DH; Miller DJ PLoS One; 2013; 8(12):e82318. PubMed ID: 24349254 [TBL] [Abstract][Full Text] [Related]
50. Marine Compounds, Mitochondria, and Malignancy: A Therapeutic Nexus. Fakhri S; Abdian S; Moradi SZ; Delgadillo BE; Fimognari C; Bishayee A Mar Drugs; 2022 Sep; 20(10):. PubMed ID: 36286449 [TBL] [Abstract][Full Text] [Related]
52. Therapeutic Application of Diverse Marine-derived Natural Products in Cancer Therapy. Yun CW; Kim HJ; Lee SH Anticancer Res; 2019 Oct; 39(10):5261-5284. PubMed ID: 31570422 [TBL] [Abstract][Full Text] [Related]
53. Marine bacteria and fungi as promising source for new antibiotics. Wiese J; Imhoff JF Drug Dev Res; 2019 Feb; 80(1):24-27. PubMed ID: 30370576 [TBL] [Abstract][Full Text] [Related]
55. A Comprehensive Review of Bioactive Peptides from Marine Fungi and Their Biological Significance. Youssef FS; Ashour ML; Singab ANB; Wink M Mar Drugs; 2019 Sep; 17(10):. PubMed ID: 31569458 [TBL] [Abstract][Full Text] [Related]
56. The combined use of alphavirus replicons and pseudoinfectious particles for the discovery of antivirals derived from natural products. Delekta PC; Raveh A; Larsen MJ; Schultz PJ; Tamayo-Castillo G; Sherman DH; Miller DJ J Biomol Screen; 2015 Jun; 20(5):673-80. PubMed ID: 25550354 [TBL] [Abstract][Full Text] [Related]
57. Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds. Srinivasan R; Kannappan A; Shi C; Lin X Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677431 [TBL] [Abstract][Full Text] [Related]
58. Drug discovery from marine microbes. Gerwick WH; Fenner AM Microb Ecol; 2013 May; 65(4):800-6. PubMed ID: 23274881 [TBL] [Abstract][Full Text] [Related]
59. Chemical Diversity and Biological Properties of Secondary Metabolites from Sea Hares of Aplysia Genus. Pereira RB; Andrade PB; Valentão P Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26907303 [TBL] [Abstract][Full Text] [Related]
60. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses. Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]